Maine Medical Center (MMC) is an independent academic medical center serving our local diverse communities, as well as serving as a tertiary referral center for the entire state of Maine. MMC currently trains over 310 residents and fellows in our 15 ACGME-accredited residency programs, 15 ACGME-accredited fellowship programs and 3 rural tracks.
The robust clinical experience is supported by high-quality didactic sessions, dedicated faculty and simulation-based teaching at the Hannaford Simulation Center. Residents have ample opportunity and mentorship to pursue scholarly research projects, quality improvement projects and health care disparity projects within their training programs. MMC is committed to promoting well-being among our graduate medical education (GME) trainees.
A Long History of Innovation
MMC has a national reputation as a leader in interprofessional, team-based training with an ACGME- and AMA- grant funded “Interprofessional Partnership to Advance Care and Education (iPACE)” grant. MMC is the flagship hospital of the MaineHealth system and is dedicated to training residents and fellows in rural training centers across the state.
MMC, along with the 3 other ACGME-accredited sponsoring institutions in Maine received a large grant to start the innovative “Maine Rural GME Education (MERGE) Collaborative" to create an infrastructure of rural GME training sites across rural Maine.
MMC is excited to announce the launch of four academic tracks to support residents and fellows who desire more specialized training during their residency program:
- Resident Research: 30-month longitudinal track for residents
- Clinical Informatics: 24-month longitudinal track for residents
- Resident Education and Leadership: (CELT): 24-month longitudinal track for residents
- Fellow Clinician Educator: 18-month longitudinal track for fellows
Like all health care workers, residents and fellows must show evidence of immune status for the following diseases and is a condition of employment:
- Varicella (chicken pox) – completed vaccine series or titer
- Measles (rubeola) – completed vaccine series or titer
- Mumps– completed vaccine series or titer
- Rubella (German measles) – completed vaccine series or titer
- Influenza (“flu”) – completed vaccine
- Sars-CoV2 (Covid-19) – completed vaccine series prior to 4/18/2023 or single bivalent booster after 4/18/2023
MaineHealth(MH) is committed to providing a safe environment for patients and staff. MH expects health care workers to perform their duties in a manner that does not jeopardize the health and safety of coworkers and patients.
The unlawful or improper presence or use of controlled substances and alcohol poses a threat to the wellbeing of patients and health care staff. Consistent with this concern for safety, MaineHealth entities make all reasonable efforts to ensure a work environment free from the effects of alcohol and drug abuse, and to comply with the Maine Substance Abuse Testing Law (26 M.R.S.A Sec. 681- 690) and the Maine Department of Labor Rules relating to Substance Abuse Testing (adopted October 27, 1989) as well as the Federal Drug Free Workplace Act. In compliance with the Drug Free Workplace Act MaineHealth follows Federal illegal and controlled substance interpretations.